Trade Summary

3 days ago, Pinion John Richard, serving as See Remarks at Ultragenyx Pharmaceutical Inc. (RARE), sold 10,029 shares at $22.80 per share, for a total transaction value of $228,661.00. Following this transaction, Pinion John Richard now holds 110,026 shares of RARE.

This sale represents a 8.00% decrease in Pinion John Richard's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Ultragenyx Pharmaceutical Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.